كيف يعاود الورم النمو بعد الصدمة الكهربائية سريع

الملخص الأصلي

كما كتبه المؤلفون، بالإنجليزية arXiv:2603.06087

Electroporation is increasingly used as a percutaneous ablation technique for tumours located near vital structures. Although effective, tumour regrowth may still occur. At the same time, in vitro studies on cell monolayers have shown that electroporation can trigger immunogenic cell death (ICD) through the release of damage-associated molecular patterns (DAMPs). These molecules can stimulate the immune system and could counteract tumour regrowth. To fully exploit electroporation, two key questions must be addressed: (1) what dynamics drive tumour regrowth, and (2) how ICD unfolds in space and time within three-dimensional cellular structures, which better mimic in vivo conditions than 2D cultures. Here, we combine in vitro experiments with a hybrid individual-based/continuous computational model to explore tumour spheroid regrowth and ICD potential under different pulse intensities. Experiments quantify spheroid viability, growth rate, and the release of ATP and HMGB1. In parallel, the hybrid model predicts the dynamics of proliferative, quiescent, and necrotic cells. Both approaches show that cell death and DAMP release scale with pulse intensity. The model, validated against experimental data, further highlights the dual role of quiescent cells: some die and free space and resources, while others survive and resume proliferation. Together, these findings demonstrate how spheroid fate depends on pulse strength and emphasize the importance of accounting for quiescent cells when designing electroporation-based therapies.